Cargando…

Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire

Introduction: Lichen planus (LP) is a chronic autoimmune disease that affects skin, oral and genital mucosa, and other sites. Basic difficulties in assessment of LP are multitude of disease forms and diverse locations of lesions. Moreover, there is lack of objective and consolidated tool for assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Stępień, Katarzyna, Żabska, Ewa, Rahnama-Hezavah, Mansur, Reich, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745608/
https://www.ncbi.nlm.nih.gov/pubmed/35011764
http://dx.doi.org/10.3390/jcm11010023
_version_ 1784630386450497536
author Stępień, Katarzyna
Żabska, Ewa
Rahnama-Hezavah, Mansur
Reich, Adam
author_facet Stępień, Katarzyna
Żabska, Ewa
Rahnama-Hezavah, Mansur
Reich, Adam
author_sort Stępień, Katarzyna
collection PubMed
description Introduction: Lichen planus (LP) is a chronic autoimmune disease that affects skin, oral and genital mucosa, and other sites. Basic difficulties in assessment of LP are multitude of disease forms and diverse locations of lesions. Moreover, there is lack of objective and consolidated tool for assessment of disease severity and LP progression. Objective: The aim of the study was to develop a valid evaluation tool of LP severity, which will enable disease assessment in a repetitive way. Materials and methods: A combined tool called Lichen Planus Activity and Damage Index (LiPADI) was developed to assess the severity of LP skin, mucosal, and nail lesions as well as hair loss/scaring alopecia to provide an integrative scoring for LP activity and damage caused by the disease. Skin lesions were assessed in nine locations: scalp, face, chest, abdomen, back and buttocks, arms, hands, legs, and feet. The assessment of lesion activity included erythema, hypertrophy, and scaling, while the damage was reflected by the assessment of hyperpigmentation and scaring/atrophy. In addition, mucosal lesions, nail abnormalities, hair loss, and scarring alopecia were evaluated as well. LiPADI scoring was compared with quality of life assessed with the Dermatology Life Quality Index, EQ-5D calculator, pain and pruritus intensity assessed with the Numerical Rating Scale as well as with the patient and physician global assessment. Results: Our results show that LiPADI well reflects the LP patient’s clinical condition. The obtained results were in line with other indicators assessed. In addition, it was possible to evaluate patients with various forms and locations of LP, what indicates its versatility. Conclusions: LiPADI seems to be a useful tool for measurement the severity of the LP and its progress over time, which could help to monitor the effectiveness of the patients’ treatment.
format Online
Article
Text
id pubmed-8745608
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87456082022-01-11 Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire Stępień, Katarzyna Żabska, Ewa Rahnama-Hezavah, Mansur Reich, Adam J Clin Med Article Introduction: Lichen planus (LP) is a chronic autoimmune disease that affects skin, oral and genital mucosa, and other sites. Basic difficulties in assessment of LP are multitude of disease forms and diverse locations of lesions. Moreover, there is lack of objective and consolidated tool for assessment of disease severity and LP progression. Objective: The aim of the study was to develop a valid evaluation tool of LP severity, which will enable disease assessment in a repetitive way. Materials and methods: A combined tool called Lichen Planus Activity and Damage Index (LiPADI) was developed to assess the severity of LP skin, mucosal, and nail lesions as well as hair loss/scaring alopecia to provide an integrative scoring for LP activity and damage caused by the disease. Skin lesions were assessed in nine locations: scalp, face, chest, abdomen, back and buttocks, arms, hands, legs, and feet. The assessment of lesion activity included erythema, hypertrophy, and scaling, while the damage was reflected by the assessment of hyperpigmentation and scaring/atrophy. In addition, mucosal lesions, nail abnormalities, hair loss, and scarring alopecia were evaluated as well. LiPADI scoring was compared with quality of life assessed with the Dermatology Life Quality Index, EQ-5D calculator, pain and pruritus intensity assessed with the Numerical Rating Scale as well as with the patient and physician global assessment. Results: Our results show that LiPADI well reflects the LP patient’s clinical condition. The obtained results were in line with other indicators assessed. In addition, it was possible to evaluate patients with various forms and locations of LP, what indicates its versatility. Conclusions: LiPADI seems to be a useful tool for measurement the severity of the LP and its progress over time, which could help to monitor the effectiveness of the patients’ treatment. MDPI 2021-12-22 /pmc/articles/PMC8745608/ /pubmed/35011764 http://dx.doi.org/10.3390/jcm11010023 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Stępień, Katarzyna
Żabska, Ewa
Rahnama-Hezavah, Mansur
Reich, Adam
Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
title Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
title_full Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
title_fullStr Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
title_full_unstemmed Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
title_short Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
title_sort lichen planus activity and damage index (lipadi)–creation of the questionnaire
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745608/
https://www.ncbi.nlm.nih.gov/pubmed/35011764
http://dx.doi.org/10.3390/jcm11010023
work_keys_str_mv AT stepienkatarzyna lichenplanusactivityanddamageindexlipadicreationofthequestionnaire
AT zabskaewa lichenplanusactivityanddamageindexlipadicreationofthequestionnaire
AT rahnamahezavahmansur lichenplanusactivityanddamageindexlipadicreationofthequestionnaire
AT reichadam lichenplanusactivityanddamageindexlipadicreationofthequestionnaire